#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Rhabdomyosarcoma recurrent Primary immunodeficiency syndrome Lymphoma Carcinoid tumour Gastrointestinal disorder Myelin oligodendrocyte glycoprotein antibody-associated disease Bladder cancer Epidermolysis bullosa Acute lymphocytic leukaemia Keratosis follicular Cervix carcinoma recurrent Peritoneal neoplasm Neuroendocrine carcinoma Infantile spasms Hypoxic-ischaemic encephalopathy More trials…
Learn about Rare Diseases

Mucopolysaccharidosis II Ocular melanoma – Treatment Erdheim-Chester disease Mucopolysaccharidosis Haemophagocytic lymphohistiocytosis – Basic Information Lymphatic malformation – Basic Information Congenital nephrogenic diabetes insipidus – Treatment Basal cell naevus syndrome – Treatment Focal segmental glomerulosclerosis – Basic Information Breast angiosarcoma metastatic – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

SAT-3247 OXALATE Folic Acid, Anhydrous Osimertinib VERCIRNON Hydrocortisone Hemisuccinate Tozorakimab Famotidine Ipn01194 PF-07868489 Enalapril Cx-039776 Meropenem Trihydrate Bms-986449-03 Vimseltinib Lithium Sulphate, Anhydrous Glofitamab Mercaptopurine Monohydrate Suxamethonium Chloride Ecoo25B Elenestinib Phosphate More therapies…

Learn about Your Condition

Endocarditis Leiomyosarcoma recurrent Procedural anxiety Labour induction Plasma cell leukaemia Breast cancer Arthritis infective Colorectal cancer stage IV Systemic sclerosis pulmonary Hand fracture Pulmonary sarcoidosis Oropharyngeal cancer recurrent Liposarcoma metastatic Biliary tract operation Graft versus host disease More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Haemophilia

A study testing fitusiran to prevent bleeding in boys aged 1 to 11 years with hemophilia A or B with or without inhibitors

Recruiting

3 1 1
Investigated Diseases:
- Haemophilia
Investigated Drugs:
- Fitusiran
+1
Study of Long-term Safety and Efficacy of Fitusiran in Patients with Hemophilia A or B with or without Inhibitory Antibodies to Factor VIII or IX

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemophilia
Investigated Drugs:
Study of Fitusiran for Preventing Bleeding in Boys Aged 1 to 12 with Hemophilia A or B

Not recruiting

4 1 1
Investigated Diseases:
- Haemophilia
Investigated Drugs:
- Fitusiran
Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemophilia
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Haemophilia

A study testing fitusiran to prevent bleeding in boys aged 1 to 11 years with hemophilia A or B with or without inhibitors

Study of Long-term Safety and Efficacy of Fitusiran in Patients with Hemophilia A or B with or without Inhibitory Antibodies to Factor VIII or IX

Study of Fitusiran for Preventing Bleeding in Boys Aged 1 to 12 with Hemophilia A or B

Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies